Loading...
Loading...
Below are the top drug manufacturers-other stocks on the NASDAQ in terms of earnings estimate for the next year.
United Therapeutics
UTHR is likely to earn $6.96 per share in the next year ending December, 2014. United Therapeutics' trailing-twelve-month ROE is 24.83%.
Endo Health Solutions
ENDP may earn $3.83 per share in the next year ending December, 2014. Endo Health's trailing-twelve-month revenue is $3.03 billion.
The Medicines Company
MDCO is projected to earn $1.15 per share for the next year ending December, 2014. Medicines Company's trailing-twelve-month operating margin is 16.42%.
Cubist Pharmaceuticals
CBST is expected to earn $1.14 per share over the next year ending December, 2014. Cubist's trailing-twelve-month ROA is 2.54%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in